3X4 Genetics Unveils Groundbreaking Genetic Insights Into Heart Disease Risk
Genetic variants linked to a 57% higher risk of heart disease are reshaping modern approaches to preventive care and influencing personalized health strategies.
3X4 Genetics, a global leader in personalized genetic testing, has announced groundbreaking findings from a recent study involving 300,000 UK participants. The research highlights key genetic variants that significantly increase the risk of coronary artery disease (CAD), one of the leading causes of death worldwide.
The study revealed that 2.3% of participants carry markers with a threefold increased CAD risk, while 6.1% have genes linked to atrial fibrillation, a leading cause of stroke. Over 50% of CAD risk is attributed to genetic predisposition.
“These findings underscore the critical role of genetic testing in hea...